ClinicalTrials.Veeva

Menu

Comparative Clinical Trial of Lornoxicam to Diclofenac in Patients of Osteoarthritis of Knee Joint.

G

Government Medical College, Bhavnagar

Status

Completed

Conditions

Osteoarthritis of Knee Joint

Treatments

Drug: Diclofenac
Drug: Lornoxicam

Study type

Interventional

Funder types

Other

Identifiers

NCT01055470
Pharmacol no.02 /2008 Research

Details and patient eligibility

About

The purpose of this study was to compare the pain relieving action of the lornoxicam and diclofenac in patients of OA knee.

Enrollment

40 patients

Sex

All

Ages

25 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newly diagnosed patient aged between 25 to 65 yrs of either gender suffering from osteoarthritis of knee according to criteria given by American College of Rheumatology
  • Informed consent obtained from the patient.

Exclusion criteria

  • Patients with any other systemic llness,
  • Patients with pregnancy and lactation,
  • Patients taking other drugs like lithium[4], digoxin, methotrexate, anticoagulants, antidiabetics, diuretics,
  • Patients with H/O hypersensitivity to NSAIDs,
  • Patients who had consumed any analgesics in last 1 month

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Diclofenac
Active Comparator group
Description:
Tab.Diclofenac 50 mg ,Orally, 12 hrly in morning and in evening after taking food for 3 months.
Treatment:
Drug: Diclofenac
Lornoxicam
Experimental group
Description:
Tab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.
Treatment:
Drug: Lornoxicam

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems